Alzheimer’s disease is the most common cause of dementia in the United Kingdom, and its exact cause is still not fully understood. Factors such as aging, genetics, depression, and cardiovascular health are all known to increase risk.

In recent years, researchers have explored whether infections might play a role in its development. One area of growing interest focuses on gum disease and the bacteria involved in poor oral health.

A 2019 study led by Jan Potempa identified the bacterium Porphyromonas gingivalis—a major cause of chronic gum disease—in the brains of some individuals who had Alzheimer’s. This finding sparked new questions about possible biological connections.

This bacterium produces enzymes known as gingipains, which laboratory studies have linked to changes in the brain associated with Alzheimer’s disease, including the buildup of amyloid-beta and tau proteins. Animal studies, particularly in mice, suggest oral infection could increase inflammation and amyloid-beta production, though this has not yet been confirmed in humans.

Researchers have also detected gingipain-related markers in people without a formal Alzheimer’s diagnosis, raising questions about whether such infections might occur before symptoms appear, or develop alongside cognitive decline. However, experts stress that this does not mean Alzheimer’s is an infectious disease.

Overall, the possible link between gum disease and Alzheimer’s disease is an intriguing area of research. It remains just one part of a much larger and evolving scientific puzzle, with no infection-based treatments yet proven effective in humans.